Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 45 to 80 years
- People who have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's disease without a known cause) according to a recognised set of medical guidelines
- People whose Parkinson's disease has been progressing for at least 3 years
- People who have been taking dopaminergic medication, including levodopa (a common Parkinson's medication), continuously for at least one year
- People who are able to understand and follow the rules and procedures set out by the trial
- People who are covered by a social security or health insurance system
- People who are willing to take part and able to give their informed consent freely
Who may not be able to join:
- People who have a neurological condition other than idiopathic Parkinson's disease
- People with severe depression, significant apathy (a lack of motivation or emotion), or notable difficulties with memory and thinking, as measured by specific tests (confirm with trial site for exact score thresholds)
- People with impulse control problems, such as issues with gambling, compulsive buying, sexual behaviour, or eating, based on a specific questionnaire score (confirm with trial site for exact score thresholds)
- People with severe movement-related symptoms, including severe shaking or uncontrolled involuntary movements, as measured by a specific motor assessment tool
- People who are under guardianship, legal protection, or who have had their personal freedoms restricted
- Women who are pregnant or breastfeeding
- People who cannot have a PET-MRI scan — for example, those with pacemakers, insulin pumps, certain metal implants, cochlear implants, claustrophobia, or certain other medical devices or conditions that are not compatible with MRI scanning (confirm with trial site for the full list)
- People who do not wish to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Charlotte BEAL, University Hospital, Clermont-Ferrand
Phone: +334.73.754.963
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
[¹¹C]raclopride binding potential (BP, unitless) measured with PET-MRI in mesocorticolimbic brain structures between participants with and without RBD, off treatment.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.